EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 199 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2017. The put-call ratio across all filers is 0.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $9,000 | -30.8% | 185 | -13.1% | 0.00% | 0.0% |
Q4 2018 | $13,000 | +44.4% | 213 | +52.1% | 0.00% | 0.0% |
Q3 2018 | $9,000 | -87.0% | 140 | -91.8% | 0.00% | -83.3% |
Q3 2017 | $69,000 | +27.8% | 1,700 | +6.2% | 0.01% | +20.0% |
Q2 2017 | $54,000 | -79.8% | 1,600 | -82.6% | 0.01% | -80.8% |
Q1 2017 | $267,000 | -29.2% | 9,183 | -20.0% | 0.03% | -43.5% |
Q4 2016 | $377,000 | +61.8% | 11,481 | +55.3% | 0.05% | +91.7% |
Q3 2016 | $233,000 | +80.6% | 7,393 | +61.6% | 0.02% | +33.3% |
Q2 2016 | $129,000 | -32.8% | 4,576 | -13.2% | 0.02% | -33.3% |
Q1 2016 | $192,000 | +163.0% | 5,274 | +137.1% | 0.03% | +170.0% |
Q2 2015 | $73,000 | +78.0% | 2,224 | +48.3% | 0.01% | +66.7% |
Q4 2014 | $41,000 | -70.9% | 1,500 | -77.3% | 0.01% | -70.0% |
Q3 2014 | $141,000 | +2.9% | 6,600 | +8.2% | 0.02% | +11.1% |
Q2 2014 | $137,000 | +953.8% | 6,100 | +1120.0% | 0.02% | +800.0% |
Q1 2014 | $13,000 | +116.7% | 500 | +47.1% | 0.00% | +100.0% |
Q3 2013 | $6,000 | – | 340 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |